Clinical, sonographic, biochemical and histopathological assessment of hepatic steatosis in Egyptian patients with HCV and HCV associated HCC

被引:0
|
作者
Elassaly, NM [1 ]
El Ray, A [1 ]
Abou Shousha, TS [1 ]
机构
[1] Theodor Bilharz Res Inst, Cairo, Egypt
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:A188 / A188
页数:1
相关论文
共 50 条
  • [21] NOVEL ULTRASONIC FIBROSCAN®-BASED STEATOSIS INDEX FOR HEPATIC STEATOSIS QUANTIFICATION IN 618 HCV PATIENTS
    Beaugrand, Michel
    Ziol, Marianne
    de Ledinghen, Victor
    Douvin, Catherine
    Marcellin, Patrick
    Poupon, Raoul
    Fournier, Celine
    Miette, Veronique
    Sasso, Magali C.
    Sandrin, Laurent
    HEPATOLOGY, 2009, 50 (04) : 773A - 773A
  • [22] PNPLA3 polymorphism is not associated with hepatic steatosis and fibrosis progression in HIV/HCV coinfected patients
    Payer, Berit A.
    Reiberger, Thomas
    Stift, Judith
    Aichelburg, Maximilian C.
    Breitenecker, Florian
    Ferenci, Peter
    Rieger, Armin
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2012, 56 : 1004A - 1004A
  • [23] Prevalence and factors associated with hepatic steatosis in HCV-HIV co-infected patients.
    Castera, L
    Neau, D
    Winnock, M
    Le Bail, B
    Geraut, L
    Dupon, M
    Lacoste, D
    Pellegrin, JL
    Trouette, H
    de Ledinghen, V
    Lafon, ME
    Bioulac-Sage, P
    Dabis, F
    HEPATOLOGY, 2004, 40 (04) : 414A - 414A
  • [24] Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients
    Allah, Hany M. M. Abdel
    Zahran, Walid E.
    El-Masry, Samir A.
    El-Bendary, Mahmoud
    Soliman, Ahmed F.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 22 (02) : 257 - 267
  • [25] Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients
    Hany M. M. Abdel Allah
    Walid E. Zahran
    Samir A. El-Masry
    Mahmoud El-Bendary
    Ahmed F. Soliman
    Clinical and Experimental Medicine, 2022, 22 : 257 - 267
  • [26] Histological characterization of HCV-associated glomerulopathy in Egyptian patients
    Sabry A.
    El-Agroudy A.
    Sheashaa H.
    El-husseini A.
    Taha N.M.
    Elbaz M.
    El-Shahat F.
    Sobh M.
    International Urology and Nephrology, 2005, 37 (2) : 355 - 361
  • [27] The impact of diabetes mellitus and steatosis on hepatic fibrosis and inflammation in HCV patients.
    Attar, BM
    Vladic, F
    Pandolfi, G
    Chinga-Alayo, E
    Orucevic, A
    Evans, AT
    Reilly, BM
    HEPATOLOGY, 2004, 40 (04) : 416A - 417A
  • [28] Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors
    Bani-Sadr, F
    Carrat, F
    Bedossa, P
    Piroth, L
    Cacoub, P
    Perronne, C
    Degott, C
    Pol, S
    AIDS, 2006, 20 (04) : 525 - 531
  • [29] HCV and HCC: Clinical Update and a Review of HCC-Associated Viral Mutations in the Core Gene
    Ahmad, Jawad
    Eng, Francis J.
    Branch, Andrea D.
    SEMINARS IN LIVER DISEASE, 2011, 31 (04) : 347 - 355
  • [30] Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
    Vecchi, Valentina Li
    Giannitrapani, Lydia
    Di Carlo, Paola
    Mazzola, Giovanni
    Colletti, Pietro
    La Spada, Emanuele
    Vizzini, Giovanni
    Montalto, Giuseppe
    Soresi, Maurizio
    ANNALS OF HEPATOLOGY, 2013, 12 (05) : 740 - 748